Table 2.
Dose | Peaks/min | Peaks/min | Inhibition (Whole Population, %) | GnRH Responders (%) | Inhibition (GnRH Responders, %) | n | N |
---|---|---|---|---|---|---|---|
SFM | ADP | ||||||
0.1 μg/mL | 1.3 ± 0.08 | 1.15 ± 0.08a | 12 ± 6 | 12 | 18 ± 8 | 85 | 3 |
0.5 μg/mL | 1.58 ± 0.05 | 1.26 ± 0.06b | 20 ± 3 | 22 | 51 ± 5 | 157 | 4 |
2 μg/mL | 1.76 ± 0.07 | 1.32 ± 0.06b | 25 ± 4 | 29 | 48 ± 5 | 226 | 6 |
5 μg/mL | 1.31 ± 0.1 | 0.8 ± 0.07b | 38 ± 6 | 25 | 55 ± 9 | 60 | 2 |
AICAR | |||||||
0.2 mM | 1.29 ± 0.06 | 1.31 ± 0.07 (NS) | 0 | 8 | 50 ± 8 | 74 | 2 |
0.5 mM | 1.45 ± 0.06 | 1.06 ± 0.06b | 26 ± 4 | 26 | 58 ± 7 | 128 | 4 |
1 mM | 0.98 ± 0.05 | 0.77 ± 0.05b | 22 ± 5 | 12 | 63 ± 8 | 116 | 4 |
t test: NS, P = .410.
P = .0008.
P < .0001.